sellModerate cluster of 410b5-1 plan
Saurabh Saha sold $918k of CNTA
Chief Executive Officer at Centessa Pharmaceuticals plc. 55,000 shares at an average of $16.69, traded Mar 20, 2025, filed Mar 21, 2025.
Warning score
49Value
$918k
55,000 shares
Holdings after
276,017
-17% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +24Trade size$918k at market
- +5Share of holdings soldSold 17% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000045, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 20, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -55,000 | $16.69 | $918k | 276,017 | Mar 21, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $210k 15,000 shares | -6% | |
| 6Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $163k 10,000 shares | -7% | |
| 5Weak | Centessa Pharmaceuticals plc | David M Chao Chief Administrative Officer | $120k 7,000 shares | -3% | |
| 5Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $99k 6,000 shares | -5% | |
| 22Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $175k 11,494 shares | -8% | |
| 48Moderate | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $876k 55,000 shares | -14% | |
| 5Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $97k 6,000 shares | -5% | |
| 24Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $589k 30,955 shares | -36% | |
| 25Weak | Centessa Pharmaceuticals plc | Karen M. Anderson Chief People Officer | $109k 6,471 shares | -11% | |
| 22Weak | Centessa Pharmaceuticals plc | Tia L Bush Chief Technology & Quality Ofc | $185k 11,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.